{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:59:22Z","timestamp":1794855562863,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41434-025-00591-0","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:59:55Z","timestamp":1768409995000},"page":"188-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["CRISPR-AuNP: physicochemical optimization of a gold nanoparticle platform for cost-effective and modular non-viral gene editing in HSPCs"],"prefix":"10.1038","volume":"33","author":[{"given":"Karthikeya S. V.","family":"Gottimukkala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleema S.","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngseo","family":"Jwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly E.","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-0620","authenticated-orcid":false,"given":"Jack M. P.","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Enstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Poljakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grady","family":"Gastelum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-0752","authenticated-orcid":false,"given":"Samuel H.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Tassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4599-016X","authenticated-orcid":false,"given":"Jennifer E.","family":"Adair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"591_CR1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816\u201321.","journal-title":"Science"},{"key":"591_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096.","journal-title":"Science"},{"key":"591_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna JA. The promise and challenge of therapeutic genome editing. Nature. 2020;578:229\u201336.","journal-title":"Nature"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/crispr.2019.0030","volume":"2","author":"SP Chen","year":"2019","unstructured":"Chen SP, Wang HH. An engineered Cas-transposon system for programmable and site-directed DNA transpositions. CRISPR J. 2019;2:376\u201394.","journal-title":"CRISPR J"},{"key":"591_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31:827\u201332.","journal-title":"Nat Biotechnol"},{"key":"591_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576:149\u201357.","journal-title":"Nature"},{"key":"591_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.amjmed.2023.12.018","volume":"137","author":"EY Adashi","year":"2024","unstructured":"Adashi EY, Gruppuso PA, Cohen IG. CRISPR therapy of sickle cell disease: the dawning of the gene editing era. Am J Med. 2024;137:390\u20132.","journal-title":"Am J Med"},{"key":"591_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul H, Altshuler D, Cappellini MD, Chen Y-S, Domm J, Eustace BK, et al. CRISPR-Cas9 Gene editing for sickle cell disease and \u03b2-thalassemia. N Engl J Med. 2021;384:252\u201360.","journal-title":"N Engl J Med"},{"key":"591_CR9","doi-asserted-by":"publisher","unstructured":"Sahu SU, Castro M, Muldoon JJ, Asija K, Wyman SK, Krishnappa N, et al. Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells. Nat Protoc. 2025. https:\/\/doi.org\/10.1038\/s41596-025-01154-8.","DOI":"10.1038\/s41596-025-01154-8"},{"key":"591_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nbt.3081","volume":"33","author":"JA Zuris","year":"2015","unstructured":"Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol. 2015;33:73\u201380.","journal-title":"Nat Biotechnol"},{"key":"591_CR11","doi-asserted-by":"publisher","first-page":"eabg2661","DOI":"10.1126\/sciadv.abg2661","volume":"7","author":"H-K Jang","year":"2021","unstructured":"Jang H-K, Jo DH, Lee S-N, Cho CS, Jeong YK, Jung Y, et al. High-purity production and precise editing of DNA base editing ribonucleoproteins. Sci Adv. 2021;7:eabg2661.","journal-title":"Sci Adv"},{"key":"591_CR12","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim S, Kim D, Cho SW, Kim J, Kim J-S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 2014;24:1012\u20139.","journal-title":"Genome Res"},{"key":"591_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15790","volume":"8","author":"HA Rees","year":"2017","unstructured":"Rees HA, Komor AC, Yeh W-H, Caetano-Lopes J, Warman M, Edge ASB, et al. Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery. Nat Commun. 2017;8:15790.","journal-title":"Nat Commun"},{"key":"591_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stem.2010.06.014","volume":"7","author":"M Mohrin","year":"2010","unstructured":"Mohrin M, Bourke E, Alexander D, Warr MR, Barry-Holson K, Le Beau MM, et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell. 2010;7:174\u201385.","journal-title":"Cell Stem Cell"},{"key":"591_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioelechem.2021.107871","volume":"141","author":"T Batista Napotnik","year":"2021","unstructured":"Batista Napotnik T, Polaj\u017eer T, Miklav\u010di\u010d D. Cell death due to electroporation\u2014a review. Bioelectrochemistry. 2021;141:107871.","journal-title":"Bioelectrochemistry"},{"key":"591_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/vox.13612","volume":"119","author":"MS Tang","year":"2024","unstructured":"Tang MS, Shan H. Current state of gene therapy in sickle cell disease. Vox Sang. 2024;119:521\u20138.","journal-title":"Vox Sang"},{"key":"591_CR17","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino CA, Harper JC, Carney JP, Timlin JA. Delivering CRISPR: a review of the challenges and approaches. Drug Deliv. 2018;25:1234\u201357.","journal-title":"Drug Deliv"},{"key":"591_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41551-023-01032-2","volume":"7","author":"DV Foss","year":"2023","unstructured":"Foss DV, Muldoon JJ, Nguyen DN, Carr D, Sahu SU, Hunsinger JM, et al. Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes. Nat Biomed Eng. 2023;7:647\u201360.","journal-title":"Nat Biomed Eng"},{"key":"591_CR19","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1016\/j.cell.2022.03.045","volume":"185","author":"A Raguram","year":"2022","unstructured":"Raguram A, Banskota S, Liu DR. Therapeutic in vivo delivery of gene editing agents. Cell. 2022;185:2806\u201327.","journal-title":"Cell"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41587-023-01756-1","volume":"42","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Baxter AE, Ren D, Qin K, Chen Z, Collins SM, et al. Efficient engineering of human and mouse primary cells using peptide-assisted genome editing. Nat Biotechnol. 2024;42:305\u201315.","journal-title":"Nat Biotechnol"},{"key":"591_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-024-03848-4","volume":"15","author":"Z Molaei","year":"2024","unstructured":"Molaei Z, Jabbarpour Z, Omidkhoda A, Ahmadbeigi N. Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells. Stem Cell Res Ther. 2024;15:233.","journal-title":"Stem Cell Res Ther"},{"key":"591_CR22","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41587-023-02078-y","volume":"42","author":"M An","year":"2024","unstructured":"An M, Raguram A, Du SW, Banskota S, Davis JR, Newby GA, et al. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat Biotechnol. 2024;42:1526\u201337.","journal-title":"Nat Biotechnol"},{"key":"591_CR23","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","volume":"23","author":"D Shi","year":"2023","unstructured":"Shi D, Toyonaga S, Anderson DG. In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles. Nano Lett. 2023;23:2938\u201344.","journal-title":"Nano Lett"},{"key":"591_CR24","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood.2022019333","volume":"142","author":"V Vavassori","year":"2023","unstructured":"Vavassori V, Ferrari S, Beretta S, Asperti C, Albano L, Annoni A, et al. Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells. Blood. 2023;142:812\u201326.","journal-title":"Blood"},{"key":"591_CR25","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/s41563-019-0385-5","volume":"18","author":"R Shahbazi","year":"2019","unstructured":"Shahbazi R, Sghia-Hughes G, Reid JL, Kubek S, Haworth KG, Humbert O, et al. Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations. Nat Mater. 2019;18:1124\u201332.","journal-title":"Nat Mater"},{"key":"591_CR26","doi-asserted-by":"publisher","unstructured":"Chen K, Han H, Zhao S, Xu B, Yin B, Lawanprasert A, et al. Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR\u2013Cas9 ribonucleoprotein. Nat Biotechnol. 2024. https:\/\/doi.org\/10.1038\/s41587-024-02437-3.","DOI":"10.1038\/s41587-024-02437-3"},{"key":"591_CR27","doi-asserted-by":"publisher","first-page":"gkaf105","DOI":"10.1093\/nar\/gkaf105","volume":"53","author":"H Karp","year":"2025","unstructured":"Karp H, Zoltek M, Wasko K, Vazquez AL, Brim J, Ngo W, et al. Packaged delivery of CRISPR\u2013Cas9 ribonucleoproteins accelerates genome editing. Nucleic Acids Res. 2025;53:gkaf105.","journal-title":"Nucleic Acids Res"},{"key":"591_CR28","doi-asserted-by":"publisher","unstructured":"Raguram A, An M, Chen PZ, Liu DR. Directed evolution of engineered virus-like particles with improved production and transduction efficiencies. Nat Biotechnol. 2024. https:\/\/doi.org\/10.1038\/s41587-024-02467-x.","DOI":"10.1038\/s41587-024-02467-x"},{"key":"591_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307796121","volume":"121","author":"CA Tsuchida","year":"2024","unstructured":"Tsuchida CA, Wasko KM, Hamilton JR, Doudna JA. Targeted nonviral delivery of genome editors in vivo. Proc Natl Acad Sci USA. 2024;121:e2307796121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"591_CR30","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1039\/D1BM01658J","volume":"10","author":"Y Lin","year":"2022","unstructured":"Lin Y, Wagner E, L\u00e4chelt U. Non-viral delivery of the CRISPR\/Cas system: DNA versus RNA versus RNP. Biomater Sci. 2022;10:1166\u201392.","journal-title":"Biomater Sci"},{"key":"591_CR31","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6:1078\u201394.","journal-title":"Nat Rev Mater"},{"key":"591_CR32","doi-asserted-by":"publisher","first-page":"e2005840","DOI":"10.1371\/journal.pbio.2005840","volume":"16","author":"B Wienert","year":"2018","unstructured":"Wienert B, Shin J, Zelin E, Pestal K, Corn JE. In vitro\u2013transcribed guide RNAs trigger an innate immune response via the RIG-I pathway. PLOS Biol. 2018;16:e2005840.","journal-title":"PLOS Biol"},{"key":"591_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-800148-6.00009-2","volume":"88","author":"P Neuberg","year":"2014","unstructured":"Neuberg P, Kichler A. Recent developments in nucleic acid delivery with polyethylenimines. Adv Genet. 2014;88:263\u201388.","journal-title":"Adv Genet"},{"key":"591_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1039\/df9511100055","volume":"11","author":"J Turkevich","year":"1951","unstructured":"Turkevich J, Peter CS, James H. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc. 1951;11:55\u201375.","journal-title":"Discuss Faraday Soc"},{"key":"591_CR35","doi-asserted-by":"publisher","first-page":"e1003606","DOI":"10.1371\/journal.pcbi.1003606","volume":"10","author":"SG Est\u00e1cio","year":"2014","unstructured":"Est\u00e1cio SG, Krobath H, Vila-Vi\u00e7osa D, Machuqueiro M, Shakhnovich EI, Fa\u00edsca PFN. A simulated intermediate state for folding and aggregation provides insights into \u0394N6 \u03b22-microglobulin amyloidogenic behavior. PLoS Comput Biol. 2014;10:e1003606.","journal-title":"PLoS Comput Biol"},{"key":"591_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nbt.3583","volume":"34","author":"L Pinello","year":"2016","unstructured":"Pinello L, Canver MC, Hoban MD, Orkin SH, Kohn DB, Bauer DE, et al. Analyzing CRISPR genome-editing experiments with CRISPResso. Nat Biotechnol. 2016;34:695\u20137.","journal-title":"Nat Biotechnol"},{"key":"591_CR37","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"591_CR38","doi-asserted-by":"publisher","first-page":"7989","DOI":"10.1093\/nar\/gkz487","volume":"47","author":"W Chen","year":"2019","unstructured":"Chen W, McKenna A, Schreiber J, Haeussler M, Yin Y, Agarwal V, et al. Massively parallel profiling and predictive modeling of the outcomes of CRISPR\/Cas9-mediated double-strand break repair. Nucleic Acids Res. 2019;47:7989\u20138003.","journal-title":"Nucleic Acids Res"},{"key":"591_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jcf.2021.05.014","volume":"21","author":"L Santos","year":"2022","unstructured":"Santos L, Mention K, Cavusoglu-Doran K, Sanz DJ, Bacalhau M, Lopes-Pacheco M, et al. Comparison of Cas9 and Cas12a CRISPR editing methods to correct the W1282X-CFTR mutation. J Cyst Fibros. 2022;21:181\u20137.","journal-title":"J Cyst Fibros"},{"key":"591_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.algal.2024.103796","volume":"84","author":"A Ferenczi","year":"2024","unstructured":"Ferenczi A, Fellbaum M, Chew YP, Kidner C, Molnar A. Comparison of CRISPR\/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii. Algal Res. 2024;84:103796.","journal-title":"Algal Res"},{"key":"591_CR41","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0039-6028(98)00015-6","volume":"402\u2013404","author":"D Zerulla","year":"1998","unstructured":"Zerulla D, Uhlig I, Szargan R, Chass\u00e9 T. Competing interaction of different thiol species on gold surfaces. Surf Sci. 1998;402\u2013404:604\u20138.","journal-title":"Surf Sci"},{"key":"591_CR42","first-page":"546","volume":"47","author":"D O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly D, Kartje ZJ, Ageely EA, Malek-Adamian E, Habibian M, Schofield A, et al. Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity. Nucleic Acids Res. 2019;47:546\u201358.","journal-title":"Nucleic Acids Res"},{"key":"591_CR43","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/127666a0","volume":"127","author":"GM Nabar","year":"1931","unstructured":"Nabar GM, Desai BN. Relation between charge and stability of colloidal gold. Nature. 1931;127:666.","journal-title":"Nature"},{"key":"591_CR44","doi-asserted-by":"publisher","first-page":"e50028","DOI":"10.1371\/journal.pone.0050028","volume":"7","author":"J Batra","year":"2012","unstructured":"Batra J, Robinson J, Mehner C, Hockla A, Miller E, Radisky DC, et al. PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1). PLoS ONE. 2012;7:e50028.","journal-title":"PLoS ONE"},{"key":"591_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5348","volume":"5","author":"Y Xue","year":"2014","unstructured":"Xue Y, Li X, Li H, Zhang W. Quantifying thiol\u2013gold interactions towards the efficient strength control. Nat Commun. 2014;5:4348.","journal-title":"Nat Commun"},{"key":"591_CR46","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1021\/jacsau.1c00128","volume":"1","author":"Q Laurent","year":"2021","unstructured":"Laurent Q, Martinent R, Lim B, Pham A-T, Kato T, L\u00f3pez-Andarias J, et al. Thiol-Mediated Uptake. JACS Au. 2021;1:710\u201328.","journal-title":"JACS Au"},{"key":"591_CR47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3324\/haematol.2010.035576","volume":"96","author":"MM Hsieh","year":"2011","unstructured":"Hsieh MM, Wu CJ, Tisdale JF. In mixed hematopoietic chimerism, the donor red cells win. Haematologica. 2011;96:13\u201315.","journal-title":"Haematologica"},{"key":"591_CR48","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.bbmt.2017.06.004","volume":"23","author":"S Chaudhury","year":"2017","unstructured":"Chaudhury S, Ayas M, Rosen C, Ma M, Viqaruddin M, Parikh S, et al. A multicenter retrospective analysis stressing the importance of long-term follow-up after hematopoietic cell transplantation for \u03b2-thalassemia. Biol Blood Marrow Transplant. 2017;23:1695\u2013700.","journal-title":"Biol Blood Marrow Transplant"},{"key":"591_CR49","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","volume":"163","author":"B Zetsche","year":"2015","unstructured":"Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 2015;163:759\u201371.","journal-title":"Cell"},{"key":"591_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1089\/crispr.2022.0089","volume":"6","author":"RC Lamothe","year":"2023","unstructured":"Lamothe RC, Storlie MD, Espinosa DA, Rudlaff R, Browne P, Liu J, et al. Novel CRISPR-associated gene-editing systems discovered in metagenomic samples enable efficient and specific genome engineering. CRISPR J. 2023;6:243\u201360.","journal-title":"CRISPR J"},{"key":"591_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1089\/crispr.2024.0080","volume":"8","author":"EA Noel","year":"2025","unstructured":"Noel EA, Sahu SU, Wyman SK, Krishnappa N, Jeans C, Wilson RC. Hairpin internal nuclear localization signals in CRISPR-Cas9 enhance editing in primary human lymphocytes. CRISPR J. 2025;8:105\u201319.","journal-title":"CRISPR J"},{"key":"591_CR52","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1101\/gr.231936.117","volume":"28","author":"S Kim","year":"2018","unstructured":"Kim S, Koo T, Jee H-G, Cho H-Y, Lee G, Lim D-G, et al. CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 2018;28:367\u201373.","journal-title":"Genome Res"},{"key":"591_CR53","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK, et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med. 2019;25:249\u201354.","journal-title":"Nat Med"},{"key":"591_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41588-022-01257-y","volume":"55","author":"S Cancellieri","year":"2023","unstructured":"Cancellieri S, Zeng J, Lin LY, Tognon M, Nguyen MA, Lin J, et al. Human genetic diversity alters off-target outcomes of therapeutic gene editing. Nat Genet. 2023;55:34\u201343.","journal-title":"Nat Genet"},{"key":"591_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol. 2015;33:187\u201397.","journal-title":"Nat Biotechnol"},{"key":"591_CR56","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.57646","volume":"10","author":"EF Cardozo-Ojeda","year":"2021","unstructured":"Cardozo-Ojeda EF, Duke ER, Peterson CW, Reeves DB, Mayer BT, Kiem H-P, et al. Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation. eLife. 2021;10:e57646.","journal-title":"eLife"},{"key":"591_CR57","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1182\/blood-2017-03-772392","volume":"130","author":"CD Fitzhugh","year":"2017","unstructured":"Fitzhugh CD, Cordes S, Taylor T, Coles W, Roskom K, Link M, et al. At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT. Blood. 2017;130:1946\u20138.","journal-title":"Blood"},{"key":"591_CR58","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.stem.2022.06.004","volume":"29","author":"C Li","year":"2022","unstructured":"Li C, Wu B, Li Y, Chen J, Ye Z, Tian X, et al. Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2\u03b1 axis. Cell Stem Cell. 2022;29:1119\u201334.e7.","journal-title":"Cell Stem Cell"},{"key":"591_CR59","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1016\/j.actbio.2012.07.015","volume":"8","author":"REB Fitzsimmons","year":"2012","unstructured":"Fitzsimmons REB, Uluda\u011f H. Specific effects of PEGylation on gene delivery efficacy of polyethylenimine: interplay between PEG substitution and N\/P ratio. Acta Biomater. 2012;8:3941\u201355.","journal-title":"Acta Biomater"},{"key":"591_CR60","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020;38:824\u201344.","journal-title":"Nat Biotechnol"},{"key":"591_CR61","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1016\/j.ymthe.2023.08.003","volume":"31","author":"K Berckmueller","year":"2023","unstructured":"Berckmueller K, Thomas J, Taha EA, Choo S, Madhu R, Kanestrom G, et al. CD90-targeted lentiviral vectors for HSC gene therapy. Mol Ther. 2023;31:2901\u201313.","journal-title":"Mol Ther"},{"key":"591_CR62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.omtm.2023.03.008","volume":"29","author":"H Wang","year":"2023","unstructured":"Wang H, Georgakopoulou A, Zhang W, Kim J, Gil S, Ehrhardt A, et al. HDAd6\/35++\u2014a new helper-dependent adenovirus vector platform for in vivo transduction of hematopoietic stem cells. Mol Ther Methods Clin Dev. 2023;29:213\u201326.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"591_CR63","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda L, Papp TE, Triebwasser MP, Yadegari A, Fedorky MT, Tanaka N, et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science. 2023;381:436\u201343.","journal-title":"Science"},{"key":"591_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn1902","volume":"16","author":"KW Doxzen","year":"2024","unstructured":"Doxzen KW, Adair JE, Fonseca Bazzo YM, Bukini D, Cornetta K, Dalal V, et al. The translational gap for gene therapies in low- and middle-income countries. Sci Transl Med. 2024;16:eadn1902.","journal-title":"Sci Transl Med"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00591-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00591-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00591-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:05:38Z","timestamp":1775574338000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00591-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1038\/s41434-025-00591-0","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JEA is a co-inventor on U.S. Patent WO2018226762A1 entitled \u201cGenomic Safe Harbors for Genetic Therapies in Human Stem Cells and Engineered Nanoparticles to Provide Targeted Genetic Therapies\u201d. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Healthy adults donated cells for this study through the Core Center of Excellence in Hematology at Fred Hutchinson Cancer Center under an approved protocol (no. 985.03), which was compliant with the Declaration of Helsinki and Belmont Report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}